Alkermes plc

Alkermes is a biopharmaceutical company. Co.'s products include: ARISTADA, which is an extended-release injectable suspension for the treatment of schizophrenia; VIVITROL, which is for the treatment of alcohol dependence and for the prevention of relapse to opioid dependence; INVEGA SUSTENNA/XEPLION, and RISPERDAL CONSTA, which is for the treatment of schizophrenia and for the treatment of schizoaffective disorder; AMPYRA/FAMPYRA, which is a treatment to improve walking in adults with multiple sclerosis; and BYDUREON is for the treatment of type 2 diabetes. Co.'s product candidate include Aripiprazole Lauroxil Two-Month Dose for the treatment of schizophrenia, among others.
  • TickerALKS
  • ISINIE00B56GVS15
  • ExchangeNASDAQ Stock Market
  • SectorPharmaceuticals & Biotechnology
  • CountryIreland

ValuEngine Rating and Forecast Report for ALKS

ValuEngine Rating and Forecast Report for ALKS

ValuEngine Rating and Forecast Report for ALKS

ValuEngine Rating and Forecast Report for ALKS

ValuEngine Rating and Forecast Report for ALKS

ValuEngine Rating and Forecast Report for ALKS

ValuEngine Rating and Forecast Report for ALKS

ValuEngine Rating and Forecast Report for ALKS

ValuEngine Rating and Forecast Report for ALKS

ValuEngine Rating and Forecast Report for ALKS

Feasibility Study Results in December to be a Catalyst for this Junior

Feasibility Study Results in December to be a Catalyst for this Junior

MarketLine Department

AdheraTherapeutics - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments

Summary Marketline's AdheraTherapeutics Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by AdheraTherapeutics since January2007. Marketline's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. K...